Dapahive-M 10/500 Tablet ER
Marketer
Vivifi Life Sciences
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Dapahive-M 10/500 Tablet ER
Dapamix-XR 10/500 Extended-Release tablets combine two medications to manage type 2 diabetes. This treatment helps regulate elevated blood glucose, thereby lowering the risk of serious diabetic complications and cardiovascular events. Dapamix-XR 10/500 may be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires medical consultation, as abrupt cessation can lead to elevated blood sugar and potentially severe consequences like kidney impairment or vision loss. This medication forms part of a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight control as directed by your doctor. Common side effects include throat irritation, nasal stuffiness, rhinorrhea, headache, nausea, emesis, and diarrhea. Adequate hydration helps prevent dehydration. Genital yeast infections are a possibility; meticulous hygiene can mitigate this risk. Prior to commencing treatment, disclose any kidney or liver issues, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Limit alcohol consumption as it may exacerbate side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Dapahive-M 10/500 Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Dapahive-M 10/500 Tablet ER
Managing Type 2 Diabetes
Major Benefits of Dapahive-M 10/500 Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Dapahive-M 10/500 Tablet ER with a meal.
Common Side effects of Dapahive-M 10/500 Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapahive-M 10/500 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapahive-M 10/500 Tablet ER whole; do not damage the tablet in any way. Administer this extended-release tablet with a meal.
How Dapahive-M 10/500 Tablet ER works:
Dapagliflozin and Metformin, combined as Dapahive-M 10/500 Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual action results in superior glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Dapahive-M 10/500 Tablet ER is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dapahive-M 10/500 tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapahive-M 10/500 tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk with the possibility of infant harm.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
The extended-release Dapahive-M 10/500 tablet requires careful administration for individuals with impaired renal function. Dosage modification of Dapahive-M 10/500 Tablet ER might be necessary. Physician consultation is advised.
LiverCAUTION
The extended-release Dapahive-M 10/500 tablet requires careful administration for individuals with hepatic impairment. Dosage modifications may be necessary. Physician consultation is advised.
What if you forget to take Dapahive-M 10/500 Tablet ER :
Should you forget to take your Dapahive-M 10/500 Tablet ER, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Dapahive-M 10/500 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


